These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

401 related articles for article (PubMed ID: 32860162)

  • 1. Analysis of the promoter regions of disease-causing genes in maturity-onset diabetes of the young patients.
    Komazec J; Ristivojevic B; Zukic B; Zdravkovic V; Karan-Djurasevic T; Pavlovic S; Ugrin M
    Mol Biol Rep; 2020 Sep; 47(9):6759-6768. PubMed ID: 32860162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maturity onset diabetes of the young (MODY) in Chinese children: genes and clinical phenotypes.
    Ming-Qiang Z; Yang-Li D; Ke H; Wei W; Jun-Fen F; Chao-Chun Z; Guan-Ping D
    J Pediatr Endocrinol Metab; 2019 Jul; 32(7):759-765. PubMed ID: 31216263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Co-inheritance of HNF1a and GCK mutations in a family with maturity-onset diabetes of the young (MODY): implications for genetic testing.
    López-Garrido MP; Herranz-Antolín S; Alija-Merillas MJ; Giralt P; Escribano J
    Clin Endocrinol (Oxf); 2013 Sep; 79(3):342-7. PubMed ID: 23009393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and laboratory clues of maturity-onset diabetes of the young and determination of association with molecular diagnosis.
    Karaoglan M; Nacarkahya G
    J Diabetes; 2021 Feb; 13(2):154-163. PubMed ID: 32710514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maturity Onset Diabetes of the Young (MODY) in Tunisia: Low frequencies of GCK and HNF1A mutations.
    Ben Khelifa S; Martinez R; Dandana A; Khochtali I; Ferchichi S; Castaño L
    Gene; 2018 Apr; 651():44-48. PubMed ID: 29408271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequency and characterization of mutations in genes in a large cohort of patients referred to MODY registry.
    Breidbart E; Deng L; Lanzano P; Fan X; Guo J; Leibel RL; LeDuc CA; Chung WK
    J Pediatr Endocrinol Metab; 2021 May; 34(5):633-638. PubMed ID: 33852230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quality of life assessment in patients with HNF1A-MODY and GCK-MODY.
    Szopa M; Matejko B; Ucieklak D; Uchman A; Hohendorff J; Mrozińska S; Głodzik W; Zapała B; Płatek T; Solecka I; Sani CM; Małecki MT
    Endocrine; 2019 May; 64(2):246-253. PubMed ID: 30421137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical application of ACMG-AMP guidelines in HNF1A and GCK variants in a cohort of MODY families.
    Santana LS; Caetano LA; Costa-Riquetto AD; Quedas EPS; Nery M; Collett-Solberg P; Boguszewski MCS; Vendramini MF; Crisostomo LG; Floh FO; Zarabia ZI; Kohara SK; Guastapaglia L; Passone CGB; Sewaybricker LE; Jorge AAL; Teles MG
    Clin Genet; 2017 Oct; 92(4):388-396. PubMed ID: 28170077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional characterization of HNF4A gene variants identify promoter and cell line specific transactivation effects.
    Kaci A; Solheim MH; Silgjerd T; Hjaltadottir J; Hornnes LH; Molnes J; Madsen A; Sjøholt G; Bellanné-Chantelot C; Caswell R; Sagen JV; Njølstad PR; Aukrust I; Bjørkhaug L
    Hum Mol Genet; 2024 May; 33(10):894-904. PubMed ID: 38433330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HNF1A gene p.I27L is associated with early-onset, maturity-onset diabetes of the young-like diabetes in Turkey.
    Beysel S; Eyerci N; Pinarli FA; Kizilgul M; Ozcelik O; Caliskan M; Cakal E
    BMC Endocr Disord; 2019 May; 19(1):51. PubMed ID: 31109344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tunisian Maturity-Onset Diabetes of the Young: A Short Review and a New Molecular and Clinical Investigation.
    Moalla M; Safi W; Babiker Mansour M; Hadj Kacem M; Mahfood M; Abid M; Kammoun T; Hachicha M; Mnif-Feki M; Hadj Kacem F; Hadj Kacem H
    Front Endocrinol (Lausanne); 2021; 12():684018. PubMed ID: 34393998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intima-media thickness and endothelial dysfunction in GCK and HNF1A-MODY patients.
    Szopa M; Osmenda G; Wilk G; Matejko B; Skupien J; Zapala B; Młynarski W; Guzik T; Malecki MT
    Eur J Endocrinol; 2015 Mar; 172(3):277-83. PubMed ID: 25501962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Common
    Locke JM; Saint-Martin C; Laver TW; Patel KA; Wood AR; Sharp SA; Ellard S; Bellanné-Chantelot C; Hattersley AT; Harries LW; Weedon MN
    Diabetes; 2018 Sep; 67(9):1903-1907. PubMed ID: 29895593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutations in the genes encoding the transcription factors hepatocyte nuclear factor 1 alpha (HNF1A) and 4 alpha (HNF4A) in maturity-onset diabetes of the young.
    Ellard S; Colclough K
    Hum Mutat; 2006 Sep; 27(9):854-69. PubMed ID: 16917892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Next generation sequencing targeted gene panel in Greek MODY patients increases diagnostic accuracy.
    Tatsi EB; Kanaka-Gantenbein C; Scorilas A; Chrousos GP; Sertedaki A
    Pediatr Diabetes; 2020 Feb; 21(1):28-39. PubMed ID: 31604004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. De novo mutations of GCK, HNF1A and HNF4A may be more frequent in MODY than previously assumed.
    Stanik J; Dusatkova P; Cinek O; Valentinova L; Huckova M; Skopkova M; Dusatkova L; Stanikova D; Pura M; Klimes I; Lebl J; Gasperikova D; Pruhova S
    Diabetologia; 2014 Mar; 57(3):480-4. PubMed ID: 24323243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Partial and whole gene deletion mutations of the GCK and HNF1A genes in maturity-onset diabetes of the young.
    Ellard S; Thomas K; Edghill EL; Owens M; Ambye L; Cropper J; Little J; Strachan M; Stride A; Ersoy B; Eiberg H; Pedersen O; Shepherd MH; Hansen T; Harries LW; Hattersley AT
    Diabetologia; 2007 Nov; 50(11):2313-7. PubMed ID: 17828387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coinheritance of HNF1A and glucokinase variants in maturity-onset diabetes of the young.
    Watanabe D; Yagasaki H; Narusawa H; Inukai T
    Endocrinol Diabetes Metab Case Rep; 2024 Jul; 2024(3):. PubMed ID: 39089324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A single dose of dapagliflozin, an SGLT-2 inhibitor, induces higher glycosuria in GCK- and HNF1A-MODY than in type 2 diabetes mellitus.
    Hohendorff J; Szopa M; Skupien J; Kapusta M; Zapala B; Platek T; Mrozinska S; Parpan T; Glodzik W; Ludwig-Galezowska A; Kiec-Wilk B; Klupa T; Malecki MT
    Endocrine; 2017 Aug; 57(2):272-279. PubMed ID: 28593615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating ghrelin level is higher in HNF1A-MODY and GCK-MODY than in polygenic forms of diabetes mellitus.
    Nowak N; Hohendorff J; Solecka I; Szopa M; Skupien J; Kiec-Wilk B; Mlynarski W; Malecki MT
    Endocrine; 2015 Dec; 50(3):643-9. PubMed ID: 25987348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.